Uploaded October 2025 | Updated September 2026, 3 days ago
At the EASD Annual Meeting 2025 in Vienna, Professor Mikael Rydén (Karolinska Institutet, Sweden) was awarded the prestigious 40th Camillo Golgi Prize, honouring his decades of groundbreaking work on adipose tissue, inflammation, and metabolic disease.
In this exclusive EASD TV interview, Prof. Rydén reflects on his journey from neurobiology to endocrinology, his pioneering research on fat cell biology and adipose tissue renewal, and how dysfunctional fat drives type 2 diabetes and related conditions. He also shares how his discoveries are shaping the future of precision medicine, linking fat cell subtypes to personalised treatment responses, including bariatric surgery and glucose-lowering drugs.
#EASD2025 #T2D #type2diabetes #precisionmedicine #obesity #diabetesresearch
At the EASD Annual Meeting 2025 in Vienna, Professor Mikael Rydén (Karolinska Institutet, Sweden) was awarded the prestigious 40th Camillo Golgi Prize, honouring his decades of groundbreaking work on adipose tissue, inflammation, and metabolic disease.
In this exclusive EASD TV interview, Prof. Rydén reflects on his journey from neurobiology to endocrinology, his pioneering research on fat cell biology and adipose tissue renewal, and how dysfunctional fat drives type 2 diabetes and related conditions. He also shares how his discoveries are shaping the future of precision medicine, linking fat cell subtypes to personalised treatment responses, including bariatric surgery and glucose-lowering drugs.
#EASD2025 #T2D #type2diabetes #precisionmedicine #obesity #diabetesresearch










